Lian Brian
President & CEO
Lian Brian has filed 3 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jul 30, 2026.
On the most recent filing, Lian Brian is listed as President & CEO at Viking Therapeutics, Inc. Inside the rolling window, Lian Brian reported no open-market purchases and 3 open-market sales totaling $14.0M in VKTX. The largest disclosed transaction in the window is a sale of 233,409 VKTX shares on Jan 5, 2026, worth $7.7M.
Companies traded
Other insiders at VKTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$14.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lian Brian made?
Lian Brian has filed 3 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does Lian Brian trade?
Lian Brian has filed SEC Form 4 disclosures for 1 company, including VKTX.
When was Lian Brian's most recent SEC Form 4 filing?
Lian Brian's most recent SEC Form 4 filing on Tracefour is dated Jul 30, 2026.
What is Lian Brian's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lian Brian is listed as President & CEO.
What is Lian Brian's total buy and sell value in the current window?
Inside the rolling retention window, Lian Brian bought $0 and sold $14.0M based on SEC Form 4 filings.
What was Lian Brian's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 233,409 VKTX shares on 2026-01-05, worth $7.7M, per SEC Form 4 filings.